Your browser doesn't support javascript.
loading
Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.
Rohila, Deepak; Park, In Hwan; Pham, Timothy V; Jones, Riley; Tapia, Elisabette; Liu, Kevin X; Tamayo, Pablo; Yu, Alice; Sharabi, Andrew B; Joshi, Shweta.
Afiliación
  • Rohila D; Division of Pediatric Hematology-Oncology, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
  • Park IH; Division of Pediatric Hematology-Oncology, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
  • Pham TV; Office of Cancer Genomics, University of California San Diego, San Diego, CA, United States.
  • Jones R; Department of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
  • Tapia E; Division of Pediatric Hematology-Oncology, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
  • Liu KX; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, United States.
  • Tamayo P; Office of Cancer Genomics, University of California San Diego, San Diego, CA, United States.
  • Yu A; Division of Pediatric Hematology-Oncology, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
  • Sharabi AB; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Joshi S; Department of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
Front Immunol ; 14: 1148317, 2023.
Article en En | MEDLINE | ID: mdl-37350973
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neuroblastoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neuroblastoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos